SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905718-18-000260
Filing Date
2018-02-16
Accepted
2018-02-16 14:44:39
Documents
1
Period of Report
2018-02-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT cymabaytherafm4am1_feb14018.html 4/A  
1 OWNERSHIP DOCUMENT cymabaytherafm4am1_feb14018.xml 4/A 5700
  Complete submission text file 0000905718-18-000260.txt   7283
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36500 | Film No.: 18620776